Le Lézard
Classified in: Health
Subjects: NEW PRODUCTS/SERVICES, CALENDAR OF EVENTS, HEALTH

ECR 2023 in Vienna, Esaote presents new ultrasound system: MyLab X90


VIENNA, Austria, March 01, 2023 (GLOBE NEWSWIRE) -- LaPresse - Esaote, a leading Italian company in ultrasound, dedicated MRI and healthcare IT, unveiled today the new MyLabtmX90 premium ultrasound system, with a ceremony dedicated to the European Society of Radiology, on the occasion of ECR 2023 in Vienna.

"MyLabtmX90 provides premium performance and it is designed to maximize diagnostic confidence and streamline workflows through automation," said Guillaume Gauthier, Global Product Marketing Manager Esaote. "Artificial intelligence is at the heart of the system. Our Augmented Insighttm includes A.I.- powered solutions with a multidisciplinary clinical approach."

"MyLabtmX90 was designed according to an operator-centric approach, to provide an unparalleled user experience," stated Florence Labb, Global Customer Marketing Manager Esaote. "Our target is making complex processes simpler and advanced technologies readily available in everyday clinical practice. With MyLabtmX90, healthcare professionals can expect a truly transformative experience in this respect."

Technology-wise, MyLabtmX90 offers premium-level components such as ClearWave architecture, XCrystal probes and an eLed monitor. MyLab X90 is the result of strategic developments and international multidisciplinary teams focused on innovation and enriches the range of ultrasound systems Esaote offers.

The ceremony took place at Esaote Booth, where it is possible to deepen features and performances of the new system throughout the duration of the Congress.

For more information:
Press Office LaPresse - [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/92cc9559-bfc0-49ba-85dc-ce5210dc4cc1

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.



These press releases may also interest you

at 05:30
Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
Spanios, a firm that created and leverages its unique 3D tumoroid platforms to validate solid tumor therapies today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC)...

at 05:00
New Affordable Assisted Living Community Opened in Valparaiso, IN
A VIP Party and Ribbon-Cutting Ceremony was held for Green Oaks of Valparaiso, a new affordable assisted lifestyle community for older adults is now...

at 04:00
The Galien Foundation Announces 2024 Prix Galien UK Award Candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical Technology," "Best Pharmaceutical Product" and "Best Public Sector Innovation"
The Galien Foundation, the premier global institution dedicated to honouring innovators in life sciences, today announced the 2024 Prix Galien UK Award candidates for "Best Biotechnology Product," "Best Digital Health Solution," "Best Medical...

at 04:00
Novo Nordisk Foundation, Rigshospitalet and CNIC press release: One in three people die due to atherosclerosis: A new initiative aims to find new ways to prevent it
Globally, cardiovascular diseases due to atherosclerosis ? the build-up of plaque in arteries ? are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and...

at 03:33
Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals
Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, has received confirmation of an extension of its contract with The Norwegian Hospital Procurement Trust (Sykehusinnkjøp HF)...

at 03:00
ALLCLEAR TRAVEL RESEARCH: ONE IN FOUR PEOPLE WITH MEDICAL CONDITIONS RISK INVALIDATING THEIR TRAVEL INSURANCE WHEN TRAVELLING ABROAD
One in four people with pre-existing medical conditions (25%) say they will not declare all of their medical conditions when buying travel insurance, with 40% of these only declaring what they are currently being treated for. Of those that would not...

More news about Health...


News published on and distributed by: